Diabetes [dsyn]
Cardiovascular disease [dsyn]
Angiotensin-converting enzyme inhibitor [phsu]
Angiotensin II Receptor Blocker [phsu]
treatment [ftcn]
Hypertension [dsyn]
Study [mnob]
Patients [podg]
Effectiveness [qlco]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Angiotensin Receptor Blockers [phsu]
primary treatment [topp]
Hypertension [dsyn]
Unknown [qlco]
Retrospective Cohort Study [resa]
Prevention [topp]
Type 2 Diabetes [dsyn]
Cardiovascular disease [dsyn]
Patients [podg]
treated [topp]
Angiotensin Receptor Blockers [phsu]
Angiotensin-Converting Enzyme Inhibitors [phsu]
Patients [podg]
Initiate [idcn]
Enalapril [aapp, phsu]
candesartan [orch, phsu]
treatment [ftcn]
Swedish [popg]
Primary Care [hlca]
centers [spco]
included [ftcn]
Medical Records [inpr]
Extracted [topp]
Link [inpr]
hospital discharge [hlca]
Registers [inpr]
Patients [podg]
Initiate [idcn]
Enalapril [aapp, phsu]
candesartan [orch, phsu]
baseline [bodm]
Characteristics [qlco]
new onset [fndg]
Diabetes [dsyn]
candesartan [orch, phsu]
Group [idcn]
Hazard Ratio [qnco]
P NOS [aapp, imft]
Compared [acty]
Enalapril [aapp, phsu]
Group [idcn]
Group [idcn]
Observed [ftcn]
Cardiovascular disease [dsyn]
Hazard Ratio [qnco]
P NOS [aapp, imft]
Patients [podg]
Discontinued [fndg]
treatment [ftcn]
Enalapril [aapp, phsu]
Group [idcn]
candesartan [orch, phsu]
Group [idcn]
Clinical setting [spco]
Patients [podg]
Initiate [idcn]
candesartan [orch, phsu]
treatment [ftcn]
Low Risk [fndg]
new onset [fndg]
Type 2 Diabetes [dsyn]
Drug [phsu]
Discontinuation [hlca]
Compared [acty]
Patients [podg]
Initiate [idcn]
Enalapril [aapp, phsu]
Cardiovascular disease [dsyn]
Observed [ftcn]
